ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 2.495
+0.035 (1.40%)
Jun 11, 2025, 3:31 PM GMT+1
ImmuPharma Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.24 | 0.21 | 0.67 | 1.65 | 5.86 | Upgrade
|
| Cash & Short-Term Investments | 0.24 | 0.21 | 0.67 | 1.65 | 5.86 | Upgrade
|
| Cash Growth | 13.63% | -68.78% | -59.51% | -71.86% | 329.50% | Upgrade
|
| Accounts Receivable | - | - | 0.17 | - | - | Upgrade
|
| Other Receivables | 0.43 | 0.69 | 1.18 | 1.13 | 0.48 | Upgrade
|
| Receivables | 0.43 | 0.69 | 1.34 | 1.13 | 0.48 | Upgrade
|
| Prepaid Expenses | 0.06 | 0.02 | 0.07 | 0.05 | 0.07 | Upgrade
|
| Other Current Assets | 0.15 | 0.43 | 0.25 | 0.51 | 1.02 | Upgrade
|
| Total Current Assets | 0.88 | 1.34 | 2.34 | 3.35 | 7.43 | Upgrade
|
| Property, Plant & Equipment | 0.08 | 0.1 | 0.39 | 0.35 | 0.41 | Upgrade
|
| Long-Term Investments | - | 0.64 | 0.69 | 1.42 | 2.42 | Upgrade
|
| Other Intangible Assets | 0.01 | 0.04 | 0.07 | 0.07 | 0.08 | Upgrade
|
| Long-Term Deferred Charges | - | 0.4 | 0.4 | 0.4 | 0.4 | Upgrade
|
| Other Long-Term Assets | - | 0.18 | 0.08 | 0.41 | 0.17 | Upgrade
|
| Total Assets | 0.98 | 2.72 | 3.97 | 6 | 10.92 | Upgrade
|
| Accounts Payable | 0.51 | 0.78 | 1.07 | 1.16 | 0.42 | Upgrade
|
| Accrued Expenses | 0.89 | 0.77 | 0.2 | 0.16 | 0.11 | Upgrade
|
| Short-Term Debt | - | - | 0 | 0 | 0 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0 | 0.64 | Upgrade
|
| Current Income Taxes Payable | 0.12 | 0.12 | 0.18 | 0.27 | 0.09 | Upgrade
|
| Total Current Liabilities | 1.52 | 1.67 | 1.45 | 1.58 | 1.26 | Upgrade
|
| Total Liabilities | 1.52 | 1.67 | 1.45 | 1.58 | 1.26 | Upgrade
|
| Common Stock | 29.81 | 29.81 | 28.98 | 28.5 | 25.02 | Upgrade
|
| Additional Paid-In Capital | 29.32 | 29.32 | 28.79 | 27.24 | 27.24 | Upgrade
|
| Retained Earnings | -65.91 | -64.08 | -61.12 | -56.58 | -45.97 | Upgrade
|
| Comprehensive Income & Other | 6.24 | 6.01 | 5.87 | 5.26 | 3.36 | Upgrade
|
| Shareholders' Equity | -0.54 | 1.06 | 2.52 | 4.41 | 9.65 | Upgrade
|
| Total Liabilities & Equity | 0.98 | 2.72 | 3.97 | 6 | 10.92 | Upgrade
|
| Total Debt | - | - | 0 | 0 | 0.64 | Upgrade
|
| Net Cash (Debt) | 0.24 | 0.21 | 0.67 | 1.65 | 5.22 | Upgrade
|
| Net Cash Growth | 13.63% | -68.78% | -59.50% | -68.42% | 290.13% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | Upgrade
|
| Filing Date Shares Outstanding | 416.44 | 416.44 | 333.4 | 284.98 | 250.22 | Upgrade
|
| Total Common Shares Outstanding | 416.44 | 416.44 | 333.4 | 284.98 | 250.22 | Upgrade
|
| Working Capital | -0.64 | -0.32 | 0.89 | 1.76 | 6.17 | Upgrade
|
| Book Value Per Share | -0.00 | 0.00 | 0.01 | 0.02 | 0.04 | Upgrade
|
| Tangible Book Value | -0.55 | 1.01 | 2.45 | 4.34 | 9.57 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.00 | 0.01 | 0.02 | 0.04 | Upgrade
|
| Machinery | 0.14 | 0.19 | 1.26 | 1.1 | 1.12 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.